Form 4: ITGR Executive's Equity Grant Vesting Signals Performance

Integer Holdings Corp's President of Cardio & Vascular, Andrew Senn, saw performance-based restricted stock units vest, reflecting achieved financial and shareholder return targets.

Summary

• Andrew Senn, President, Cardio & Vascular at Integer Holdings Corp (ITGR), reported the vesting of 2,340 shares of common stock from performance-based restricted stock units (PSUs).
• These PSUs vested due to the satisfaction of specified financial performance targets based on organic sales growth achievement for the years 2023, 2024, and 2025.
• An additional 2,380 shares of common stock vested from PSUs based on the satisfaction of 3-year relative total shareholder return goals.
• A disposition of 1,447 shares of common stock occurred at a price of $84.85 per share, likely for tax withholding purposes related to the vesting.
• Following these transactions, Andrew Senn beneficially owns 14,813 shares of common stock directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive indicator of past company performance, as executive performance-based units vested due to achieved targets for organic sales growth and total shareholder return.

Positives

• The vesting of 4,720 performance-based restricted stock units indicates that Integer Holdings Corp successfully met its specified financial performance targets for organic sales growth for 2023, 2024, and 2025.
• The vesting also confirms the achievement of the company's 3-year relative total shareholder return goals, aligning executive incentives with shareholder value creation.

Negatives

• A disposition of 1,447 shares of common stock occurred, reducing the net increase in direct beneficial ownership from the gross vested amount, likely due to tax obligations.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that the vesting of performance-based restricted stock units (PSUs) is a standard practice in executive compensation across the medical device industry. This mechanism aligns executive incentives with the company's strategic objectives and shareholder interests, rewarding leadership for achieving predefined financial and market performance benchmarks.

Comparison to Industry Standards

• The use of performance-based restricted stock units tied to organic sales growth and relative total shareholder return is a common and well-regarded practice in executive compensation within the medical technology sector, similar to compensation structures seen at companies like Medtronic, Stryker, and Boston Scientific.
• The vesting of these units indicates that Integer Holdings Corp's performance metrics, such as organic sales growth and TSR, met or exceeded the targets set for the respective periods (2023-2025 for sales growth, 3-year for TSR), suggesting competitive operational and market performance.

Stakeholder Impact

• Shareholders: The vesting of performance-based units signals that the company has met its financial and shareholder return targets, which is generally positive for shareholder confidence and reflects effective management.
• Employees: Successful achievement of company-wide performance targets can positively impact employee morale and potentially future incentive programs.

Key Dates

Recommendation

The filing details routine vesting of performance-based restricted stock units for an executive, indicating past performance targets were met. While positive, it does not provide new fundamental information to warrant a change in investment recommendation, as such vestings are typically anticipated when performance goals are achieved.

Keywords

Integer Holdings Corp, ITGR, Andrew Senn, Form 4, Insider Transaction, Executive Compensation, Performance Stock Units, PSU Vesting, Organic Sales Growth, Total Shareholder Return